METABOLIC FEATURES OF GASTROESOPHAGEAL REFLUX DISEASE IN ADOLESCENTS
Abstract
The article presents our own research data on the study of metabolic characteristics of adolescents with gastroesophageal reflux disease (GERD), including obese patients. The objective of the study was to assess the metabolic characteristics of non-erosive and erosive clinical forms of GERD in adolescents and justify further differentiated correction of metabolic disorders.
Materials and Methods. 35 healthy adolescents (Group I – the controls) and 81 children aged 15–17 years with GERD (Group II – the main group) were examined, including 47 patients with non-erosive reflux disease (NERD) (Subgroup IIn) and 34 patients with erosive reflux esophagitis (ERE) (Subgroup IIe), including 9 obese girls. Metabolic features were studied by measuring the levels of 78 organic acids (OA) in urine using gas chromatography-mass spectrometry (GC-MS). The obtained results were statistically processed using generally accepted methods of medical statistics.
Results. Every 10th patient with GERD had lipoic acid and vitamins B1, B2, B3, and B5 deficiency, while 48.7% of adolescents with NERD and 2/3 of patients with ERE had vitamin B6 deficiency. An elevated orotate level (a biomarker of magnesium deficiency) was found in every third patient in Subgroup IIn and in 64.7% of patients in Subgroup IIe, which was also confirmed by the indicators of other metabolites (lactate, pyruvate, succinate, citrate, 2-ketoglutaric acid). Patients with GERD (29.8% and 52.9% in Subgroups IIn and IIe) significantly more often had elevated levels of hydroxyproline dipeptide (a marker of bone and connective tissue disorders), which were 2 times higher in ERE patients vs. NERD patients and 3 times higher in ERE patients vs. the controls. In 42.6% of patients with NERD and 85.3% of patients with ERE, especially in those with obesity (88.9%), metabolic markers of intestinal microbiome disorders were detected. They can support the inflammatory process in the esophageal mucosa and contribute to the disease's progression and require appropriate correction.
Conclusion. In adolescents with non-erosive and erosive forms of GERD, especially if accompanied by obesity, a complex of metabolic disorders in carbohydrate, protein, and fat metabolism was identified, which requires further study and differentiated correction. The non-invasive GC-MS screening method used to measure urinary OА levels makes it possible to identify the main metabolic disorders in GERD in adolescents, allowing differential correction of disease therapy and control of its effectiveness and duration.
Downloads
References
Ye X, Yu F, Zhou J, Zhao C, Wu J, Ni X. Analysis of the gut microbiota in children with gastroesophageal reflux disease using metagenomics and metabolomics. Front Cell Infect Microbiol. 2023;13:1267192. https://doi.org/10.3389/fcimb.2023.1267192. PMID: 37900308; PMCID: PMC10613033.
Jaworska N., MacQueen G. (2015). Adolescence as a unique developmental period. Journal of Psychiatry & Neuroscience. 40 (5):291–293. https://doi.org/10.1503/jpn.150268
Kesavelu D, Franklyn N, Venkatraghavan C, Narayan D, P Ravindra K, Wasim A. Prevalence and Severity of Gastroesophageal Reflux Disease in Indian Children Presenting with Symptoms of Acid Reflux: A Real-world Evidence Study. Turk Arch Pediatr. 2025 Jan 27;60(3):341-343. https://doi.org/10.5152/TurkArchPediatr.2025.24140. PMID: 39873348; PMCID: PMC12093388.
Xie M, Deng L, Fass R, Song G. Obesity is associated with higher prevalence of gastroesophageal reflux disease and reflux related complications: A global healthcare database study. Neurogastroenterol Motil. 2024 Apr;36(4):e14750. https://doi.org/10.1111/nmo.14750. Epub 2024 Jan 31. PMID: 38297487.
Andrásdi Z, Müller KE, Gaál Z, Nemes É, Felszeghy E. Health related quality of life is associated with gastroesophageal reflux symptoms in overweight children. Journal of Pediatric Endocrinology and Metabolism. 2024;37(1): 27-32. https://doi.org/10.1515/jpem-2023-0315
Sintusek P, Mutalib M, Thapar N. Gastroesophageal reflux disease in children: What's new right now? World J Gastrointest Endosc. 2023 Mar 16;15(3):84-102. https://doi.org/10.4253/wjge.v15.i3.84. PMID: 37034973; PMCID: PMC10080553.
D'Souza SM., Houston K, Keenan L, Yoo BS, Parekh PJ, Johnson DA. (2021). Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria? World J. Gastroenterol. 2021;27: 2054–2072. https://doi.org/10.3748/wjg.v27.i18.2054
Sharma P, Yadlapati R. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid. Ann. N Y Acad. Sci. 2021;1486: 3–14. https://doi.org/10.1111/nyas.14501
Dicks LMT. Gut bacteria and neurotransmitters. Microorganisms. 2022;10: 1838. https://doi.org/10.3390/microorganisms10091838
Bardanzellu F, Fanos V. How could metabolomics change pediatric health?. Ital J Pediatr, 2020;46:37. https://doi.org/10.1186/s13052-020-0807-7
Filimoniuk A, Daniluk U, Samczuk P, Wasilewska N, Jakimiec P, Kucharska M, Lebensztejn DM, Ciborowski M. Metabolomic profiling in children with inflammatory bowel disease. Adv Med Sci. 2020 Mar;65(1):65-70. https://doi.org/10.1016/j.advms.2019.12.009. Epub 2020 Jan 2. PMID: 31901795.
Jagt JZ, Verburgt CM, de Vries R, de Boer NKH, Benninga MA, de Jonge WJ, van Limbergen JE, de Meij TGJ. Faecal Metabolomics in Paediatric Inflammatory Bowel Disease: A Systematic Review. J Crohns Colitis. 2022 Nov 23;16(11):1777-1790. https://doi.org/10.1093/ecco-jcc/jjac079. PMID: 35679608; PMCID: PMC9683079.
Garibay-Nieto N, Pedraza-Escudero K, Omaña-Guzmán I, Garcés-Hernández MJ, Villanueva-Ortega E, Flores-Torres M, Pérez-Hernández JL, León-Hernández M, Laresgoiti-Servitje E, Palacios-González B, López-Alvarenga JC, Lisker-Melman M, Vadillo-Ortega F. Metabolomic Phenotype of Hepatic Steatosis and Fibrosis in Mexican Children Living with Obesity. Medicina, 2023;59(10):1785. https://doi.org/10.3390/medicina59101785
Du L, Zhang K, Liang L, Yang Y, Lu D, Zhou Y, Ren T, Fan J, Zhang H, Wang Y, Jiang L. 2025. Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease. mSystems 10:e01148-24. https://doi.org/10.1128/msystems.01148-24
Babu M, Gaurav T, Vipul G, Vasundhra B, Nupur S, Manisha Y, Sushmita P, Neha S, Abhishak GC, Sadam H, Akhilesh SK, Vikrant S, Lal, Bihari LB, Seema A, Rajeev Kh, Singh MJ. Circulating bacterial peptides and linked metabolomic signatures are indicative of early mortality in pediatric cirrhosis. Hepatology Communications. 2024;8(6):e0440. | https://doi.org/10.1097/HC9.0000000000000440
Luo M, Luo J, Kaminga AC et al. Targeted metabolomics reveals bioactive inflammatory mediators from gut into blood circulation in children with NAFLD. npj Biofilms Microbiomes 11, 119 (2025). https://doi.org/10.1038/s41522-025-00706-w
Sinclair EM, Cohen CC, Tran V, Jones DP, Alvarez JA, Kamaleswaran R, Rad MG et al. Untargeted, High-Resolution Metabolomics in Pediatric Eosinophilic Esophagitis. JPGN, 27 December 2022;76(3):355-363. https://doi.org/10.1097/MPG.0000000000003693
Rose C, Parker A, Jefferson B, Cartmell E. The Characterization of Feces and Urine: A Review of the Literature to Inform Advanced Treatment Technology. Critical Reviews in Environmental Science and Technology (англ.). 2015;45(17):1827-1879. doi:10.1080/10643389.2014.1000761
Gill PA, Inniss S, Kumagai T, Rahman FZ, Smith AM. The role of diet and gut microbiota in regulating gastrointestinal and inflammatory disease. Front. Immunol. 2022;13:866059. https://doi.org/10.3389/fimmu.2022.866059
Jia B, Han X, Kim KH, Jeon CO. Discovery and mining of enzymes from the human gut microbiome. Trends Biotechnol. 2022;40:240–254. https://doi.org/10.1016/j.tibtech.2021.06.008
Gastro-oesophageal reflux disease in children and young people: diagnosis and management" NICE guideline [NG1] 2015, updated 2019.
Order of the Ministry of Health of Ukraine dated 06/29/2023 No. 1179 On approval of the standard of medical care "Gastroesophageal reflux disease in children". Retrived from https://moz.gov.ua/uk/decrees/nakaz-moz-ukraini-vid-29062023--1179-pro-zatverdzhennja-standartu-medichnoi-dopomogi-gastroezofagealna-refljuksna-hvoroba-u-ditej
Asreah R, Abdullhameed A. Risk factors of erosive esophagitis and barrett’s esophagus in patients with reflux symptoms. Med J Islam Repub Iran . 2021 (Jun 12);35:75. https://doi.org/10.47176/mjiri.35.75
Facts about Vitamin B6 Fact Sheet for Health Professionals. Office of Dietary Supplements at National Institutes of Health. 2020. Archived from the original on April 18, 2011. Retrieved from https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/
Da Silva VR, Gregory III JF. Vitamin B6. In BP Marriott, DF Birt, VA Stallings, AA Yates (eds.). Present Knowledge in Nutrition, Eleventh Edition. London, United Kingdom: Academic Press (Elsevier). 2022;225–38. ISBN 978-0-323-66162-1
Cazzola R, Della Porta M, Piuri G, Maier JA. Magnesium: A Defense Line to Mitigate Inflammation and Oxidative Stress in Adipose Tissue. Antioxidants 2024,13(8):893. https://doi.org/10.3390/antiox13080893
Dietary Supplement Fact Sheet: Magnesium. Office of Dietary Supplements, US National Institutes of Health. 11 February 2016. Retrieved from https://ods.od.nih.gov/factsheets/magnesium-HealthProfessional/
Office of Dietary Supplements - Magnesium. Retrieved from: https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
Magnesium. The Fertilizer Institute. Archived from the original (PDF) on 18 March 2023. Retrieved 14 July 2023.
Khudoyarova D, Shodikulova G, Yunusova Z. Features of the course of pregnancy in patients with connective tissue dysplasia. Eurasian Journal of Medical and Natural Sciences. 2024;4(10):164–174. https://inacademy.uz/index.php/EJMNS/article/view/38743
Mishchuk VG, Romash IB. Features of manifestation of undifferentiated connective tissue dysplasia syndrome and indicators of collagen metabolism in its combination with gastroesophageal reflux disease. Modern Gastroenterology. 2019;107(3):9-25. https://doi.org/https://doi.org/10.30978/MG-2019-3-19
Takeuchi T, Kameyama K, Miyauchi E, Nakanishi Y, Kanaya T, Fujii T, Kato T, Sasaki T, Tachibana N, Negishi H, Matsu M, Ohno H. Fatty acid overproduction by gut commensal microbiota exacerbates obesity. Cell Metab. 2023;35:361–e3759.
Liu Y, Yu J, Yang Y, Bingiu H. Wang Q, Shiyu D. Investigating the causal relationship of gut microbiota with GERD and BE: a bidirectional mendelian randomization. BMC Genomics. 2024;25:471. https://doi.org/10.1186/s12864-024-10377-0
Kim M-H, Yun KE, Kim J, Park E, Chang Y, Ryu S, Kim H-L, Kim H-N. Gut microbiota and metabolic health among overweight and obese individuals. Sci Rep. 2020;10:19417. https://doi.org/10.1038/s41598-020-76474-8
Qiu B, Shen Z, Yang D, Qin X, Ren W, Wang Q. Gut microbiota and common gastrointestinal diseases: a bidirectional two-sample mendelian randomized study. Front Microbiol. 2023;14:1273269. https://doi.org/10.3389/fmicb.2023.1273269
Wang K, Wang S, Chen Y, Lu X, Wang D, Zhang Y, Pan W, Zhou C, Zou D. Causal relationship between gut microbiota and risk of gastroesophageal reflux disease: a genetic correlation and bidirectional Mendelian randomization study. Front Immunol. 2024;15:1327503. https://doi.org/10.3389/fimmu.2024.1327503. PMID: 38449873; PMCID: PMC10914956.
Parhomenko OV, Ostapchuk VV, Komlyk VO, Brygadyrenko VV. Influence of medicinal plants on Blaberus craniifer cockroaches and their parasites, gregarines and nematodes. Biosystems Diversity, 2024:32(3), 398–405. https://doi.org/10.15421/012443

This work is licensed under a Creative Commons Attribution 4.0 International License.

























